https://imagionbiosystems.com/wp-content/uploads/2
Post# of 128
"Together, these results suggest that our anti-HER2 antibody conjugated nanoparticles are safe; can provide targeted and specific delivery to cancerous tissue in vivo and generate measurable signal on our MRX detection instrument. These studies lay out ground work for our future human clinical study for breast cancer detection."